"Surgery Partners Receives 'Hard Pass' in Cramer's Lightning Round"

Jim Cramer advises against investing in Surgery Partners due to the volatility of the industry, recommends buying Energy Transfer, expresses uncertainty about DigitalOcean's stock performance, discourages investing in Vodafone while suggesting Verizon instead, and acknowledges CRISPR Therapeutics' potential but cautions against its current financial situation. He also notes that MP Materials' stock has been stagnant but does not oppose it.